查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595250

兒科介入性心臟病學市場：按產品類型、應用分類 - 全球預測 2025-2030

Pediatric Interventional Cardiology Market by Product Type (Angioplasty Balloons, Angioplasty Stents, Atherectomy Devices), Application (Angioplasty, Congenital Heart Defect Correction, Coronary Thrombectomy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年兒科介入性心臟病學市場價值為22.6億美元，預計2024年將達到25.6億美元，複合年成長率為13.92%，到2030年將達到56億美元，預計將達到3000萬美元。

小兒介入性心臟病學是專注於診斷和治療兒童先天性和後天性心臟疾病的微創技術的專業。該領域包括廣泛的手術，包括球囊血管成形術、心臟瓣膜和血管支架置入術以及在即時成像技術下進行的心臟缺陷裝置閉合術。對這項專業的需求源於解決先天性心臟疾病（CHD）（最常見的出生缺陷）的迫切需求。透過早期療育干預，該領域最大限度地減少了心臟直視手術的需要，並顯著縮短了年輕患者的康復時間。其應用範圍擴展到醫院、兒科心臟中心，甚至門診設施，旨在改善兒科患者的心臟功能和整體生活品質。

主要市場統計
基準年[2023] 22.6億美元
預測年份 [2024] 25.6億美元
預測年份 [2030] 56.3億美元
複合年成長率（%） 13.92%

市場促進因素包括醫療技術的進步、冠心病患病率的增加以及對早期診斷和治療的日益重視。最新的商機在於整合人工智慧和機器學習等最尖端科技進行預測分析並提高介入手術的精確度。企業也應該專注於遠端醫療和遠端監控解決方案，這些解決方案在疫情後勢頭強勁，在該領域具有巨大潛力。然而，治療成本高、缺乏熟練的從業人員以及嚴格的監管合規等挑戰仍然存在，這可能會阻礙市場的成長。

技術創新旨在開發用於植入設備的生物相容性材料，改善診斷影像技術以提高手術的精確度，以及個人化醫療方法來為個別患者量身定做治療方案。此外，對恢復時間短的微創手術的研究可能會顯著改變兒科循環系統的模式。該市場技術創新的快速步伐需要持續的研發投資以及與學術機構的合作，以提高品質和效率。這些領域的重點策略將增強我們的競爭優勢，並確保兒科介入性心臟病學領域的持續進步。

市場動態：快速發展的兒科介入性心臟病學市場的關鍵市場洞察

供需的動態交互作用正在改變兒科介入性心臟病學市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 兒童先天性心臟疾病率增加
    • 公眾意識的提高以及政府的積極努力
    • 與傳統手術相比，人們越來越偏好微創手術
  • 市場限制因素
    • 治療和治療費用高
  • 市場機會
    • 在引進尖端生物可吸收支架方面不斷取得進展
    • 活性化兒科介入性心臟病學的研究和開發
  • 市場挑戰
    • 監理程序複雜嚴格

波特五力：駕馭兒科介入性心臟病學市場的策略工具

波特的五力框架是了解兒科介入性心臟病學市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解兒科介入性心臟病學市場的外部影響

外部宏觀環境因素在塑造兒科介入性心臟病學市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解兒科介入性心臟病學市場的競爭格局

對兒科介入性心臟病學市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣兒科介入性心臟病學市場供應商的績效評估

FPNV 定位矩陣是評估兒童介入性心臟病學市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了兒科介入心臟病學市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對兒科介入性心臟病學市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 兒童先天性心臟疾病發生率增加
      • 提高公眾意識和有利的政府舉措
      • 微創手術比傳統手術越來越受青睞
    • 抑制因素
      • 治療和治療費用高
    • 機會
      • 引進先進生物可吸收支架的持續進展
      • 擴大兒科介入性心臟病學的研發活動
    • 任務
      • 監理程序複雜嚴格
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章兒科介入性心臟病學市場：依產品類型

  • 血管成形術用氣球
  • 血管成形術支架
  • 斑塊切除裝置
  • 氣球充氣裝置
  • 導管
  • 導管導引線

第7章兒科介入性心臟病學市場：依應用分類

  • 血管成形術
  • 先天性心臟疾病矯正
  • 冠狀動脈血栓切除術
  • 經皮皮瓣修復術
  • 經皮瓣膜置換術術
  • 瓣環成形

第8章美洲兒科介入性心臟病學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區兒科介入性心臟病學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的兒科介入性心臟病學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Getinge AB
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Lifetech Scientific（Shenzhen）Co., Ltd.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • NuMED
  • Occlutech Holding AG
  • OSYPKA AG
  • Siemens Healthineers AG
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-8A35583B127E

The Pediatric Interventional Cardiology Market was valued at USD 2.26 billion in 2023, expected to reach USD 2.56 billion in 2024, and is projected to grow at a CAGR of 13.92%, to USD 5.63 billion by 2030.

Pediatric Interventional Cardiology is a specialized field focusing on minimally invasive techniques to diagnose and treat congenital and acquired heart diseases in children. This scope includes a wide range of procedures, such as balloon angioplasty, stenting of the heart valves or blood vessels, and device closures of heart defects, performed under real-time imaging techniques. The necessity for this specialty arises from the critical need to address congenital heart defects (CHDs)-the most common birth defect. By allowing early intervention, this field minimizes the need for open-heart surgery and significantly improves recovery times in young patients. Applications span hospital settings, specialized pediatric cardiac centers, and even outpatient facilities, aimed at enhancing cardiac function and overall quality of life for pediatric patients.

KEY MARKET STATISTICS
Base Year [2023] USD 2.26 billion
Estimated Year [2024] USD 2.56 billion
Forecast Year [2030] USD 5.63 billion
CAGR (%) 13.92%

Market insights reveal several growth drivers, such as advancements in medical technology, an increasing prevalence of CHDs, and a growing emphasis on early diagnosis and treatment. Latest opportunities lie in integrating cutting-edge technologies like AI and machine learning for predictive analytics, enhancing precision in interventional procedures. Companies should also focus on telemedicine and remote monitoring solutions, which have gained momentum post-pandemic and present substantial potential in this domain. However, challenges persist, including high procedural costs, a shortage of skilled practitioners, and stringent regulatory compliance, which can impede market growth.

Innovation should target the development of biocompatible materials for implantable devices, improved imaging techniques for better procedural accuracy, and personalized medicine approaches to tailor treatments individualistically. Additionally, research into less-invasive procedures with shorter recovery times could substantially transform the landscape of pediatric cardiology. The market is influenced by a high pace of technological change, requiring continuous R&D investments and partnerships with academic institutions to drive quality and efficiency. Focused strategies on these areas can bolster competitive advantage and ensure sustainable progress in the pediatric interventional cardiology sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Interventional Cardiology Market

The Pediatric Interventional Cardiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of congenital heart conditions among pediatric patients
    • Growing awareness among the population coupled with favorable government initiatives
    • Rising preference for minimally invasive procedures over traditional surgeries
  • Market Restraints
    • High cost of treatments and therapies
  • Market Opportunities
    • Ongoing advancements for the introduction of advanced bio-absorbable stents
    • Growing research and development activities in pediatric interventional cardiology
  • Market Challenges
    • Complex and strict regulatory procedures

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Interventional Cardiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Interventional Cardiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Interventional Cardiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Interventional Cardiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Interventional Cardiology Market

A detailed market share analysis in the Pediatric Interventional Cardiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Interventional Cardiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Interventional Cardiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Interventional Cardiology Market

A strategic analysis of the Pediatric Interventional Cardiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Interventional Cardiology Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cardinal Health, Inc., Edwards Lifesciences Corporation, GE Healthcare, Getinge AB, Lepu Medical Technology (Beijing) Co., Ltd., Lifetech Scientific (Shenzhen) Co., Ltd., Medtronic PLC, MicroPort Scientific Corporation, NuMED, Occlutech Holding AG, OSYPKA AG, Siemens Healthineers AG, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Interventional Cardiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Angioplasty Balloons, Angioplasty Stents, Atherectomy Devices, Balloon Inflation Devices, Catheters, and Guidewires.
  • Based on Application, market is studied across Angioplasty, Congenital Heart Defect Correction, Coronary Thrombectomy, Percutaneous Valve Repair, Percutaneous Valve Replacement, and Valvuloplasty.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of congenital heart conditions among pediatric patients
      • 5.1.1.2. Growing awareness among the population coupled with favorable government initiatives
      • 5.1.1.3. Rising preference for minimally invasive procedures over traditional surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements for the introduction of advanced bio-absorbable stents
      • 5.1.3.2. Growing research and development activities in pediatric interventional cardiology
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and strict regulatory procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Interventional Cardiology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Angioplasty Balloons
  • 6.3. Angioplasty Stents
  • 6.4. Atherectomy Devices
  • 6.5. Balloon Inflation Devices
  • 6.6. Catheters
  • 6.7. Guidewires

7. Pediatric Interventional Cardiology Market, by Application

  • 7.1. Introduction
  • 7.2. Angioplasty
  • 7.3. Congenital Heart Defect Correction
  • 7.4. Coronary Thrombectomy
  • 7.5. Percutaneous Valve Repair
  • 7.6. Percutaneous Valve Replacement
  • 7.7. Valvuloplasty

8. Americas Pediatric Interventional Cardiology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pediatric Interventional Cardiology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pediatric Interventional Cardiology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cardinal Health, Inc.
  • 3. Edwards Lifesciences Corporation
  • 4. GE Healthcare
  • 5. Getinge AB
  • 6. Lepu Medical Technology (Beijing) Co., Ltd.
  • 7. Lifetech Scientific (Shenzhen) Co., Ltd.
  • 8. Medtronic PLC
  • 9. MicroPort Scientific Corporation
  • 10. NuMED
  • 11. Occlutech Holding AG
  • 12. OSYPKA AG
  • 13. Siemens Healthineers AG
  • 14. Terumo Corporation
  • 15. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CORONARY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PERCUTANEOUS VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PERCUTANEOUS VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVULOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 108. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023